Company Filing History:
Years Active: 2018
Title: Yves Meyvis: Innovator in Immunoglobulin Formulations
Introduction
Yves Meyvis is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of immunology through his innovative work on stable formulations of immunoglobulin single variable domains. His research focuses on enhancing the stability and usability of these formulations in pharmaceutical applications.
Latest Patents
Yves Meyvis holds a patent for "Stable formulations of immunoglobulin single variable domains." This invention relates to stable formulations of polypeptides, particularly immunoglobulin single variable domains directed against von Willebrand Factor (vWF). The formulations developed by Meyvis ensure high stability during storage over prolonged periods and across a broad range of temperatures. They allow for multiple freeze-thaw cycles without chemical or physical deterioration and maintain stability under mechanical stress, making them suitable for pharmaceutical and diagnostic preparations.
Career Highlights
Meyvis is associated with Ablynx N.V., a company known for its innovative approaches in biopharmaceuticals. His work has contributed to advancements in the stability and efficacy of therapeutic formulations, which are crucial for patient care and treatment outcomes.
Collaborations
Some of his notable coworkers include Veronique De Brabandere and Hans Ulrichts, who have collaborated with him on various projects within the company.
Conclusion
Yves Meyvis is a prominent figure in the field of immunology, with a focus on developing stable formulations that enhance the effectiveness of therapeutic proteins. His contributions continue to impact the pharmaceutical industry positively.